QIAGEN N.V. is a company organized under the laws of the Netherlands and is listed on NYSE and in the Prime Standard Segment of the Frankfurt Stock Exchange in Germany. As such, the Company is subject to laws, rules and regulations including such of the Netherlands, the United States of America and Germany.
QIAGEN has always placed the highest standards on its corporate governance principles. Since 1997, QIAGEN has endorsed the 40 recommendations made in the report of the Netherlands Committee on Corporate Governance, which was replaced by the Dutch Corporate Governance Code on the 1st of January 2004. It is the Company's policy to follow the guidelines for Good Practice of Corporate Governance as described in this Code although some minor deviations may result from effects such as legal requirements imposed on QIAGEN or industry standards.
QIAGEN also is subject to the rules regarding corporate governance set by NYSE, where the Company's shares are listed.
For further information regarding filings, rules and regulations please also refer to the U.S. Securities and Exchange Commission, the Authority of Financial Markets in the Netherlands and the Bundesanstalt für Finanzdienstleistungsaufsicht in Germany).